| Name | Osborn Drugs |
|---|---|
| Organization Name | Osborn Drugs No 2 Inc |
| Location | 207 W Illinois Ave, Vinita, Oklahoma 74301 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (918) 256-6459 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Please be advised that Gallup and Healthways, Inc. today released the Gallup-Healthways Monthly U.S. Well-Being Report for December 2010.
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced results of a meta-analysis study of the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device. Six-month clinical results from 91 U.S. and European patients with ischemic heart failure were presented at the 2013 EuroPCR Conference in Paris by Dr. Martyn Thomas, M.D., chairman of Cardiology at St. Thomas Hospital in London, England.
Senescence, a phenomenon in which cells cease to divide and grow, can be caused by everything from natural DNA damage to treatment with chemotherapy. However, several mechanisms allow for cells to bypass senescence and grow out of control, eventually becoming cancerous.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced that SenterNovem, an agency of the Dutch Ministry of Economic Affairs, has granted the company a loan under its new Innovation Credit scheme of potentially up to EUR 5 million to finance the further clinical development of its unique new hemostat Fibrocaps(TM).
Mesothelioma is a rare, aggressive type of cancer with no cure. However, the latest data from the Australian Institute of Health and Welfare suggests survival is improving.
› Verified 8 days ago
| NPI Number | 1073560298 |
| Organization Name | OSBORN DRUGS NO 2 INC |
| Doing Business As | OSBORN DRUGS |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 207 W Illinois Ave, Vinita, OK 74301 |
| Phone Number | 918-256-6459 |
News Archive
Please be advised that Gallup and Healthways, Inc. today released the Gallup-Healthways Monthly U.S. Well-Being Report for December 2010.
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced results of a meta-analysis study of the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device. Six-month clinical results from 91 U.S. and European patients with ischemic heart failure were presented at the 2013 EuroPCR Conference in Paris by Dr. Martyn Thomas, M.D., chairman of Cardiology at St. Thomas Hospital in London, England.
Senescence, a phenomenon in which cells cease to divide and grow, can be caused by everything from natural DNA damage to treatment with chemotherapy. However, several mechanisms allow for cells to bypass senescence and grow out of control, eventually becoming cancerous.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced that SenterNovem, an agency of the Dutch Ministry of Economic Affairs, has granted the company a loan under its new Innovation Credit scheme of potentially up to EUR 5 million to finance the further clinical development of its unique new hemostat Fibrocaps(TM).
Mesothelioma is a rare, aggressive type of cancer with no cure. However, the latest data from the Australian Institute of Health and Welfare suggests survival is improving.
› Verified 8 days ago
News Archive
Please be advised that Gallup and Healthways, Inc. today released the Gallup-Healthways Monthly U.S. Well-Being Report for December 2010.
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced results of a meta-analysis study of the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device. Six-month clinical results from 91 U.S. and European patients with ischemic heart failure were presented at the 2013 EuroPCR Conference in Paris by Dr. Martyn Thomas, M.D., chairman of Cardiology at St. Thomas Hospital in London, England.
Senescence, a phenomenon in which cells cease to divide and grow, can be caused by everything from natural DNA damage to treatment with chemotherapy. However, several mechanisms allow for cells to bypass senescence and grow out of control, eventually becoming cancerous.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced that SenterNovem, an agency of the Dutch Ministry of Economic Affairs, has granted the company a loan under its new Innovation Credit scheme of potentially up to EUR 5 million to finance the further clinical development of its unique new hemostat Fibrocaps(TM).
Mesothelioma is a rare, aggressive type of cancer with no cure. However, the latest data from the Australian Institute of Health and Welfare suggests survival is improving.
› Verified 8 days ago
James K Butner Od Type: Medicare Supplier Location: 529 N Wilson St, Vinita, Oklahoma 74301 Phone: (918) 256-5543 | |
Osborn Drugs Type: Durable Medical Equipment & Medical Supplies Supplier Location: 207 W Illinois Ave, Vinita, Oklahoma 74301 Phone: (918) 256-6459 | |
Sherl Moore, Od, Pllc Type: Medicare Supplier Location: 120 W Delaware Ave, Vinita, Oklahoma 74301 Phone: (918) 256-5646 | |
Walmart Pharmacy 10-0050 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 268 S 7th St, Vinita, Oklahoma 74301 Phone: (918) 256-6435 |